December 28, 2017 / 6:27 AM / 24 days ago

BRIEF-RaQualia Pharma says termination of 5-HT4 partial agonist related license agreement

Dec 28 (Reuters) - RaQualia Pharma Inc

* Says co and South Korea-based firm CJ HealthCare terminate 5-HT4 partial agonist (RQ-00000010) related license agreement

Source text in Japanese: goo.gl/Q7i2tF

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below